GlassScriptPhysician profile
John Charles Dugal
NPI 1851482665
$3,423.10
in general payments reported to CMS, 2019-2025
21 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,473 · 2020: $213 · 2021: $279 · 2022: $597 · 2023: $480 · 2024: $254 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,914.89 | 2019-2023 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $209.80 | 2022-2024 | Impella |
| Abbott Laboratories | $202.81 | 2019-2022 | |
| Medtronic, INC. | $200.40 | 2022-2023 | Corevalve Evolut R |
| Atricure, INC. | $162.39 | 2023-2024 | |
| Bolton Medical INC | $93.50 | 2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Baxter Healthcare | $83.44 | 2019-2022 | |
| Stryker Corporation | $69.64 | 2020-2023 | Na |
| La Jolla Pharmaceutical Company | $69.30 | 2019-2023 | Giapreza |
| Portola Pharmaceuticals, LLC | $66.63 | 2019-2020 | |
| Angiodynamics, INC. | $60.82 | 2019 | |
| Biomerieux INC | $49.65 | 2019 | |
| Ethicon US, LLC | $46.55 | 2019-2025 | Evarrest, Vistaseal |
| Kls-Martin L.P. | $41.71 | 2019 | |
| Intuitive Surgical, INC. | $35.70 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $34.93 | 2023 | Manta |
| Astrazeneca Pharmaceuticals LP | $22.39 | 2021 | |
| Corcym INC | $19.79 | 2024 | Perceval |
| Alexion Pharmaceuticals, INC. | $16.27 | 2021 | |
| Karl Storz Endoscopy-America | $11.95 | 2019 | |
| Veran Medical Technologies, INC. | $10.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dugal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.